364
Views
67
CrossRef citations to date
0
Altmetric
Opening lecture

Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR)

, , &
Pages 193-195 | Published online: 18 Aug 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Yusuke Takahashi, Kazuhiro Oguchi, Yusuke Mochizuki, Ken Takasone, Naoki Ezawa, Akira Matsushima, Nagaaki Katoh, Masahide Yazaki & Yoshiki Sekijima. (2023) Distribution and progression of cerebral amyloid angiopathy in early-onset V30M (p.V50M) hereditary ATTR amyloidosis. Amyloid 30:1, pages 109-118.
Read now
Marco Luigetti, Angela Romano, Andrea Di Paolantonio, Giulia Bisogni & Mario Sabatelli. (2020) Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care. Therapeutics and Clinical Risk Management 16, pages 109-123.
Read now
Maria C. Azevedo Coutinho, Nuno Cortez-Dias, Guilhermina Cantinho, Susana Gonçalves, Miguel Nobre Menezes, Tatiana Guimarães, Gustavo Lima da Silva, Ana Rita Francisco, João Agostinho, Laura Santos, Isabel Conceição & Fausto J. Pinto. (2020) The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease. Amyloid 27:3, pages 174-183.
Read now
Karla Cárdenas-Soto, Benjamín Torres-Octavo, Claudia Mendoza-Tejeda, Omar Fueyo-Rodríguez, Carolina Domínguez-Rico & Alejandra Gonzalez-Duarte. (2019) Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations. Amyloid 26:sup1, pages 57-58.
Read now
Joel N. Buxbaum, Thomas Brannagan$suffix/text()$suffix/text(), Juan Buades-Reinés, Eugenia Cisneros, Isabel Conceicao, Theodoros Kyriakides, Giampaolo Merlini, Laura Obici, Violaine Plante-Bordeneuve, Antoine Rousseau, Yoshiki Sekijima, Akira Imai, Márcia Waddington Cruz & Masahito Yamada. (2019) Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis. Amyloid 26:1, pages 10-14.
Read now
Vincent Algalarrondo, Teresa Antonini, Marie Théaudin, Denis Chemla, Anouar Benmalek, Denis Castaing, Cécile Cauquil, François Rouzet, Delphine Mika, Eric Duong, Sylvie Dinanian, Ludivine Eliahou, Dominique Le Guludec, Didier Samuel, David Adams & Michel S. Slama. (2018) Cause of death analysis and temporal trends in survival after liver transplantation for transthyretin familial amyloid polyneuropathy. Amyloid 25:4, pages 253-260.
Read now
Hirofumi Jono & Yukio Ando. (2017) Towards targets and treatments in transthyretin amyloidosis. Expert Opinion on Orphan Drugs 5:9, pages 691-699.
Read now
Paola Marmiroli & Guido Cavaletti. (2016) Drugs for the treatment of peripheral neuropathies. Expert Opinion on Pharmacotherapy 17:3, pages 381-394.
Read now
Kosuke Okumura, Taro Yamashita, Teruaki Masuda, Yohei Misumi, Akihiko Ueda, Mitsuharu Ueda, Konen Obayashi, Hirofumi Jono, Satoshi Yamashita, Yukihiro Inomata & Yukio Ando. (2016) Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation. Amyloid 23:1, pages 39-45.
Read now
Philip N. Hawkins, Yukio Ando, Angela Dispenzeri, Alejandra Gonzalez-Duarte, David Adams & Ole B. Suhr. (2015) Evolving landscape in the management of transthyretin amyloidosis. Annals of Medicine 47:8, pages 625-638.
Read now
David Adams, Cecile Cauquil, Marie Theaudin, Antoine Rousseau, Vincent Algalarrondo & Michel S Slama. (2014) Current and future treatment of amyloid neuropathies. Expert Review of Neurotherapeutics 14:12, pages 1437-1451.
Read now
Elisabet Ihse, Claudio Rapezzi, Giampaolo Merlini, Merrill D. Benson, Yukio Ando, Ole B. Suhr, Shu-ichi Ikeda, Francesca Lavatelli, Laura Obici, Candida C. Quarta, Ornella Leone, Hirofumi Jono, Mitsuharu Ueda, Massimiliano Lorenzini, Juris Liepnieks, Toshinori Ohshima, Masayoshi Tasaki, Taro Yamashita & Per Westermark. (2013) Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis. Amyloid 20:3, pages 142-150.
Read now
A De Pasqual, Y Biessaux, N Blettard, S Crémers & J Caers. (2013) UNEXPLAINED CARDIAC FAILURE LEADING TO THE IDENTIFICATION OF A BELGIAN FAMILY AFFECTED BY HEREDITARY AMYLOIDOSIS. Acta Clinica Belgica 68:4, pages 303-305.
Read now

Articles from other publishers (54)

Antonia Carroll, P James Dyck, Mamede de Carvalho, Marina Kennerson, Mary M Reilly, Matthew C Kiernan & Steve Vucic. (2022) Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis. Journal of Neurology, Neurosurgery & Psychiatry 93:6, pages 668-678.
Crossref
Kaitlyn M. Tracy, Lea K. Matsuoka & Sophoclis P. Alexopoulos. (2022) Update on combined heart and liver transplantation: evolving patient selection, improving outcomes, and outstanding questions. Current Opinion in Organ Transplantation Publish Ahead of Print.
Crossref
Y. Zhang, Z. Liu, Y. Zhang, H. Wang, X. Liu, S. Zhang, X. Liu & D. Fan. (2020) Corneal sub‐basal whorl‐like nerve plexus: a landmark for early and follow‐up evaluation in transthyretin familial amyloid polyneuropathy. European Journal of Neurology 28:2, pages 630-638.
Crossref
Efthimios Dardiotis, Savanna Andreou, Athina-Maria Aloizou, Elena Panayiotou, Vasileios Siokas, Mihaela Nedea Ioannou, Emmelia Vounou, Kyproula Christodoulou, George A. Tanteles, Demos Michaelides & Theodoros Kyriakides. (2020) The frequency of central nervous system complications in the Cypriot cohort of ATTRV30M neuropathy transplanted patients. Neurological Sciences 41:5, pages 1163-1170.
Crossref
Foteini Theodorakakou, Despina Fotiou, Meletios A. Dimopoulos & Efstathios Kastritis. (2020) Solid Organ Transplantation in Amyloidosis. Acta Haematologica 143:4, pages 352-364.
Crossref
Deepa M. Gopal, Frederick L. Ruberg & Omar K. Siddiqi. (2019) Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis. Current Heart Failure Reports 16:5, pages 180-188.
Crossref
Kourosh Rezania & Laleh Saadat. 2019. Amyloid Diseases. Amyloid Diseases.
Kelly Graham Gwathmey & Kathleen T Pearson. (2019) Diagnosis and management of sensory polyneuropathy. BMJ, pages l1108.
Crossref
Josef Finsterer, Stephan Iglseder, Julia Wanschitz, Raffi Topakian, Wolfgang N. Löscher & Wolfgang Grisold. (2019) Hereditary transthyretin-related amyloidosis. Acta Neurologica Scandinavica 139:2, pages 92-105.
Crossref
Yuya Hayashi & Hirofumi Jono. (2018) Recent Advances in Oligonucleotide-Based Therapy for Transthyretin Amyloidosis: Clinical Impact and Future Prospects. Biological and Pharmaceutical Bulletin 41:12, pages 1737-1744.
Crossref
N. Andrés, J.J. Poza & J.F. Martí Massó. (2018) Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area. Neurología (English Edition) 33:9, pages 583-589.
Crossref
N. Andrés, J.J. Poza & J.F. Martí Massó. (2018) Polineuropatía amiloidótica familiar I por mutación Val50Met (Val30Met) en el gen de la transtiretina. Neurología 33:9, pages 583-589.
Crossref
Qian Chen, Lamei Yuan, Xiong Deng, Zhijian Yang, Shengwang Zhang, Sheng Deng, Hongwei Lu & Hao Deng. (2017) A Missense Variant p.Ala117Ser in the Transthyretin Gene of a Han Chinese Family with Familial Amyloid Polyneuropathy. Molecular Neurobiology 55:6, pages 4911-4917.
Crossref
Dipti Banerjee, Lindsey E. Roeker, Martha Grogan, Paul Swiecicki, John Poterucha, Julie Heimbach, Steve Zeldenrust, Morie Gertz, Brooks Edwards, Richard Daly, Kyle W. Klarich & Angela Dispenzieri. (2017) Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation. Progress in Transplantation 27:3, pages 246-250.
Crossref
Jeannine Hoepfner, Mandy Kleinsorge, Oliver Papp, Susanne Alfken, Robin Heiringhoff, Andreas Pich, Vanessa Sauer, Andree Zibert, Gudrun Göhring, Hartmut Schmidt, Malte Sgodda & Tobias Cantz. (2017) In vitro modelling of familial amyloidotic polyneuropathy allows quantitative detection of transthyretin amyloid fibril-like structures in hepatic derivatives of patient-specific induced pluripotent stem cells. Biological Chemistry 398:8, pages 939-954.
Crossref
Matthew Sousa, Gregory Monohan, Navin Rajagopalan, Alla Grigorian & Maya Guglin. (2017) Heart transplantation in cardiac amyloidosis. Heart Failure Reviews 22:3, pages 317-327.
Crossref
Natalie J. Galant, Per Westermark, Jeffrey N. HigakiAvijit Chakrabartty. (2017) Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy. Clinical Science 131:5, pages 395-409.
Crossref
Vincent Algalarrondo, Teresa Antonini, Marie Théaudin, Denis Chemla, Anouar Benmalek, Catherine Lacroix, Denis Castaing, Cécile Cauquil, Sylvie Dinanian, Ludivine Eliahou, Didier Samuel, David Adams, Dominique Le Guludec, Michel S. Slama & François Rouzet. (2016) Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver Transplantation. JACC: Cardiovascular Imaging 9:12, pages 1432-1441.
Crossref
Rajshekhar Chakraborty, Eli Muchtar & Morie A. Gertz. (2016) Newer Therapies for Amyloid Cardiomyopathy. Current Heart Failure Reports 13:5, pages 237-246.
Crossref
F. Lagarto, B. Gomes, P. Sá Couto, F. Correia de Barros, Z. Moreira, T. Branco, L. Fonseca, J. Aguiar, I. Aragão, H.P. Miranda, J. Daniel & S. Esteves. (2016) Perioperative Predictors of Survival After Liver Transplantation for Familial Amyloid Polyneuropathy in a Portuguese Center. Transplantation Proceedings 48:6, pages 2098-2101.
Crossref
Richard M. Steingart, Carol Chen & Jennifer Liu. 2016. Clinical Cardio-Oncology. Clinical Cardio-Oncology 121 131 .
Bijan Eghtesad & Charles Miller. 2016. Disease Recurrence After Liver Transplantation. Disease Recurrence After Liver Transplantation 135 144 .
Paul J. Thuluvath. 2016. Disease Recurrence After Liver Transplantation. Disease Recurrence After Liver Transplantation 1 11 .
Laerke M. Nelson, Luit Penninga, Gerda E. Villadsen, Henning Mølgaard, Hans Eiskjaer, Jens G. Hillingsø & Allan Rasmussen. (2015) Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy. Clinical Transplantation 29:12, pages 1098-1104.
Crossref
Yvonne S. Eisele, Cecilia Monteiro, Colleen Fearns, Sandra E. Encalada, R. Luke Wiseman, Evan T. Powers & Jeffery W. Kelly. (2015) Targeting protein aggregation for the treatment of degenerative diseases. Nature Reviews Drug Discovery 14:11, pages 759-780.
Crossref
Yoshiki Sekijima. (2015) Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. Journal of Neurology, Neurosurgery & Psychiatry 86:9, pages 1036-1043.
Crossref
Pablo García-Pavía, Francisco Muñoz-Beamud & Carlos Casasnovas. (2015) Recomendaciones para el diagnóstico y tratamiento de la polineuropatía amiloidótica familiar por transtiretina. Medicina Clínica 145:5, pages 211-217.
Crossref
Pablo García-Pavía, Francisco Muñoz-Beamud & Carlos Casasnovas. (2015) Recommendations regarding diagnosis and treatment of transthyretin familial amyloid polyneuropathy. Medicina Clínica (English Edition) 145:5, pages 211-217.
Crossref
Simon Dubrey, Elizabeth Ackermann & Julian Gillmore. (2015) The transthyretin amyloidoses: advances in therapy. Postgraduate Medical Journal 91:1078, pages 439-448.
Crossref
Alberto A. Marcacuzco Quinto, Alejandro Manrique Municio, Luis C. Jimenez Romero, Carmelo Loinaz Segurola, Jorge Calvo Pulido, Iago Justo Alonso, Alvaro Garcia-Sesma Perez-F, Manuel Abradelo de Usera, Felix Cambra Molero, Oscar Caso M & Enrique Moreno Gonzalez. (2015) Trasplante hepático como tratamiento de la polineuropatía amiloidótica familiar en pacientes mayores de 60 años. Medicina Clínica 144:9, pages 385-388.
Crossref
Alberto A. Marcacuzco Quinto, Alejandro Manrique Municio, Luis C. Jimenez Romero, Carmelo Loinaz Segurola, Jorge Calvo Pulido, Iago Justo Alonso, Alvaro Garcia-Sesma Perez-F, Manuel Abradelo de Usera, Felix Cambra Molero, Oscar Caso M & Enrique Moreno Gonzalez. (2015) Liver transplantation as treatment of familial amyloid polyneuropathy in patients older than 60 years. Medicina Clínica (English Edition) 144:9, pages 385-388.
Crossref
J. M. Morrow & M. M. Reilly. (2015) Early detection of nerve injury in transthyretin-related familial amyloid polyneuropathy. Brain 138:3, pages 507-509.
Crossref
Thibaud Damy, Daniel P. Judge, Arnt V. Kristen, Karine Berthet, Huihua Li & Janske Aarts. (2015) Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients with non-Val30Met and non-Val122Ile Hereditary Transthyretin Amyloidosis. Journal of Cardiovascular Translational Research 8:2, pages 117-127.
Crossref
Andreia Carvalho, Ana Rocha & Luísa Lobato. (2015) Liver transplantation in transthyretin amyloidosis: Issues and challenges. Liver Transplantation 21:3, pages 282-292.
Crossref
Mitsuharu Ueda & Yukio Ando. (2014) Recent advances in transthyretin amyloidosis therapy. Translational Neurodegeneration 3:1.
Crossref
Simon W Dubrey & Sarah Ghonim. (2014) Amyloid heart disease (part 2): Management and specific treatments. British Journal of Cardiac Nursing 9:7, pages 330-335.
Crossref
Y. Sekijima. (2014) Recent progress in the understanding and treatment of transthyretin amyloidosis. Journal of Clinical Pharmacy and Therapeutics 39:3, pages 225-233.
Crossref
Violaine Plante-Bordeneuve. (2014) Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy. Journal of Neurology 261:6, pages 1227-1233.
Crossref
David Adams, Pierre Lozeron & Vincent Algalarrondo. (2014) Utilisation de l’ARN interférence dans le traitement de l’amylose héréditaire due à une mutation de la transthyrétine. médecine/sciences 30:4, pages 345-347.
Crossref
David Adams, Marie Théaudin, Cecile Cauquil, Vincent Algalarrondo & Michel Slama. (2014) FAP Neuropathy and Emerging Treatments. Current Neurology and Neuroscience Reports 14:3.
Crossref
Rafael S Pinheiro, Quirino Lai, Carola Dahrenmoller & Jan Lerut. (2014) Complex hepatic outflow reconstruction in domino liver transplantation. Hepatobiliary & Pancreatic Diseases International 13:1, pages 98-100.
Crossref
Taimur SherMorie A Gertz. (2014) Recent advances in the diagnosis and management of cardiac amyloidosis. Future Cardiology 10:1, pages 131-146.
Crossref
Luís Gales & Jeffrey K. Aronson. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions 747 761 .
P. Lozeron, M. Théaudin, Z. Mincheva, B. Ducot, C. Lacroix & D. Adams. (2013) Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy. European Journal of Neurology 20:12, pages 1539-1545.
Crossref
Giampaolo Merlini, Violaine Planté-Bordeneuve, Daniel P. Judge, Hartmut Schmidt, Laura Obici, Stefano Perlini, Jeff Packman, Tara Tripp & Donna R. Grogan. (2013) Effects of Tafamidis on Transthyretin Stabilization and Clinical Outcomes in Patients with Non-Val30Met Transthyretin Amyloidosis. Journal of Cardiovascular Translational Research 6:6, pages 1011-1020.
Crossref
T. M. Antonini, P. Lozeron, C. Lacroix, Z. Mincheva, A. Durrbach, M. Slama, E. Vibert, D. Samuel & D. Adams. (2013) Reversibility of Acquired Amyloid Polyneuropathy After Liver Retransplantation. American Journal of Transplantation 13:10, pages 2734-2738.
Crossref
Maria C. Azevedo CoutinhoNuno Cortez-DiasGuilhermina CantinhoIsabel ConceiçãoAntónio OliveiraArmando Bordalo e SáSusana GonçalvesAna G. AlmeidaMamede de CarvalhoAntónio Nunes Diogo. (2013) Reduced Myocardial 123-Iodine Metaiodobenzylguanidine Uptake. Circulation: Cardiovascular Imaging 6:5, pages 627-636.
Crossref
Clemens Franz, Katrin Hoffmann, Ulf Hinz, Reinhard Singer, Ernst Hund, Daniel N. Gotthardt, Tom Ganten, Arnt Volko Kristen, Ute Hegenbart, Stefan Schönland, Katrin Hinderhofer, Markus W. Büchler & Peter Schemmer. (2013) Modified body mass index and time interval between diagnosis and operation affect survival after liver transplantation for hereditary amyloidosis: a single‐center analysis. Clinical Transplantation 27:s25, pages 40-48.
Crossref
Bouke P.C. Hazenberg. (2013) Amyloidosis. Rheumatic Disease Clinics of North America 39:2, pages 323-345.
Crossref
David Adams. (2012) Recent advances in the treatment of familial amyloid polyneuropathy. Therapeutic Advances in Neurological Disorders 6:2, pages 129-139.
Crossref
David Adams, Pierre Lozeron & Catherine Lacroix. (2012) Amyloid neuropathies. Current Opinion in Neurology 25:5, pages 564-572.
Crossref
David Adams, Didier Samuel & Michel Slama. (2012) Traitement des neuropathies amyloïdes héréditaires. La Presse Médicale 41:9, pages 793-806.
Crossref
Joel N. Buxbaum & Reinhold P. Linke. (2012) A Molecular History of the Amyloidoses. Journal of Molecular Biology 421:2-3, pages 142-159.
Crossref
Jay S. Dalal, Kevin Barton & Maria M. Picken. 2012. Amyloid and Related Disorders. Amyloid and Related Disorders 377 391 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.